Back to search

Michigan State University

Modulation of HIVGP120 antigen-specific immune responses, in vitro and in vivo, by Delta9-tetrahydrocannabinol and cannabinoid receptors 1 and 2

Abstract

dc:description

"Approximately 25% of HIV patients use marijuana for its putative therapeutic benefit; however, it is unknown how cannabinoids affect the immune function of immunocompromised HIV patients at the early stage. The goal of these studies was to investigate the immunomodulatory effects of cannabinoids on the early stage of the anti-HIV immune responses... " -- Abstract.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Chen, Weimin
Contributors dc:contributor
  • Kaminski, Norbert E.
  • Amalfitano, Andrea
  • Kaplan, Barbara
  • Pestka, James
  • Yu, Kefei

Subjects

dc:subject × 7

Rights

dc:rights
Statement dc:rights
  • In Copyright
Language dc:language
English

Identifiers

dc:identifier.*
Identifier
etd:3043
isbn:9781303823107
isbn:1303823101
oclc:931761181
umi:3615823
local:Chen_grad.msu_0128D_12720

Chain of custody

source
Harvested from
Michigan State University
Base URL
d.lib.msu.edu/oai
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chen, Weimin. Modulation of HIVGP120 antigen-specific immune responses, in vitro and in vivo, by Delta9-tetrahydrocannabinol and cannabinoid receptors 1 and 2. 2014. https://doi.org/doi:10.25335/fbpw-4138